Author(s):
Jitendra Yadav, Dolly Dewangan, Kamraj, Krity Gupta, Manish Kumar Sahu, Parimal Verma, Prashant Kumar Sahu, Shweta Sinha, Aakanksha Sinha, S. J. Daharwal
Email(s):
jy7288096@gmail.com
DOI:
10.52711/2231-3915.2025.00010 
Address:
Jitendra Yadav*, Dolly Dewangan, Kamraj, Krity Gupta, Manish Kumar Sahu, Parimal Verma, Prashant Kumar Sahu, Shweta Sinha, Aakanksha Sinha, S. J. Daharwal
University Institute of Pharmacy, Pt. Ravishankar Shukla University, Raipur (C.G).
*Corresponding Author
Published In:
Volume - 15,
Issue - 2,
Year - 2025
ABSTRACT:
Bifonazole, an antifungal drug of the imidazole class, works by rupturing the fungal cell membrane, which kills the fungus and treats superficial fungal skin diseases.The drug development process involves continuous, interconnected activities for the development and validation of analytical methodologies. The primary objective of its development and validation is to determine the accuracy, specificity, precision, and robustness of the proposed analytical method for the pharmaceutical industry's analysis of drug moiety. The pharmaceutical formulations drug discovery, development, and evaluation require the establishment of a technique. An analytical method must be validated to show that it is appropriate and suitable for the intended use, which is often a necessary precondition for analytical purposes. This article focusses on the validation of Bifonazole and creation of various analytical method developments that are used in various dosage forms.
Cite this article:
Jitendra Yadav, Dolly Dewangan, Kamraj, Krity Gupta, Manish Kumar Sahu, Parimal Verma, Prashant Kumar Sahu, Shweta Sinha, Aakanksha Sinha, S. J. Daharwal. A Review of Estimation Techniques for Bifonazole in Pharmaceutical Formulations. International Journal of Technology. 2025; 15(2):51-5. doi: 10.52711/2231-3915.2025.00010
Cite(Electronic):
Jitendra Yadav, Dolly Dewangan, Kamraj, Krity Gupta, Manish Kumar Sahu, Parimal Verma, Prashant Kumar Sahu, Shweta Sinha, Aakanksha Sinha, S. J. Daharwal. A Review of Estimation Techniques for Bifonazole in Pharmaceutical Formulations. International Journal of Technology. 2025; 15(2):51-5. doi: 10.52711/2231-3915.2025.00010 Available on: https://ijtonline.com/AbstractView.aspx?PID=2025-15-2-1
REFERENCE:
1. Rieth H. Bifonazole. Basel: Karger Publishers; 1985. doi:10.1159/isbn.978-3-318-01573-7
2. Wheatley D, Richardson MD, Scott EM. Tinea Infections Treated with Bifonazole Gel/Dermatophytosen‐Behandlung mit Bifonazol‐Gel. Mycoses. 1988 Sep; 31(9): 471-5..
3. Egbuta C, Lo J, Ghosh D. Mechanism of inhibition of estrogen biosynthesis by azole fungicides. Endocrinology. 2014 Dec 1; 155(12): 4622-8.
4. Faergemann J. Treatment of seborrhoeic dermatitis with bifonazole. Mycoses. 1989 Jun; 32(6): 309-11..
5. Ahmad K, Khan MK, Baig MH, Imran M, Gupta GK. Role of azoles in cancer prevention and treatment: present and future perspectives. Anti-Cancer Agents in Medicinal Chemistry-Anti-Cancer Agents). 2018 Jan 1; 18(1):46-56.
6. Wächtler B, Wilson D, Hube B. Candida albicans adhesion to and invasion and damage of vaginal epithelial cells: stage-specific inhibition by clotrimazole and bifonazole. Antimicrobial Agents and Chemotherapy. 2011 Sep;55(9):4436-9.
7. Adriana PT. Havard’s Nursing Guide to Drugs.
8. Čakar M, Popović G. Spectrophotometric determination of Bifonazole and Clotrimazole in lotions Bicutrin® and Canesten®. Arhiv za Farmaciju. 2004; 54(1-2):1-3.
9. Mushik OV, Tkach VI, Karandeeva NI, Glukhova OI, Tsyganok LP. Electrochemical and analytical properties of solid-contact ion-selective electrodes reversible to the imidazole derivatives clotrimazole and bifonazole. Journal of Analytical Chemistry. 1998; 53(12): 1110-2.
10. Drabińska B, Dettlaff K, Ratajczak T, Kossakowski K, Chmielewski MK, Cielecka-Piontek J, Kujawski J. Structural and spectroscopic properties of isoconazole and bifonazole—experimental and theoretical studies. International Journal of Molecular Sciences. 2022 Dec 28; 24(1): 520..
11. Fromtling RA. Overview of medically important antifungal azole derivatives. Clinical Microbiology Reviews. 1988 Apr; 1(2): 187-217..
12. Ma, Miao, Jidong Wang, Xiaotong Yang, and Zhong Zhao. Determination and Simulation of the Solubility of Bifonazole in 14 Pure Solvents at 283.15–323.15 K. Journal of Chemical and Engineering Data. 2023: 68(7): 1748-1762.
13. Yarlagadda DL, Kawakami K, Samavedi S. Leveraging Molecular Interactions to Develop a Generalized Design Framework for Coamorphous Drug–Drug Mixtures Exhibiting Elevated Glass Transition Temperatures. Molecular Pharmaceutics. 2025 May 16; 22(6): 3084-96.
14. Deep, Aman, Manish Kumar, Rakesh Pahwa, Sumeet Gupta, Shailendra Bhatt, Beena Kumari, Prabhat Kumar Upadhyay, and A. Pandurangan. Formulation and in vivo pharmacodynamics studies of nanostructured lipid carriers for topical delivery of bifonazole. ACTA Pharmaceutica Sciencia. 2021; 59(1).
15. Rajendiran A, Rawat S, Singh A, Parveen A, Goutham S. Role of azole antifungal agents in seborrheic dermatitis and dandruff: a review. World Journal of Pharmaceutical Research. 2021 July;12(10):367-386.
16. Lackner TE, Clissold SP. Bifonazole: a review of its antimicrobial activity and therapeutic use in superficial mycoses. Drugs. 1989 Aug; 38(2): 204-225.
17. Drusano GL. Antimicrobial pharmacodynamics: critical interactions of'bug and drug. Nature Reviews Microbiology. 2004 Apr 1; 2(4): 289-300.
18. Andes D, Van Ogtrop M. In vivo characterization of the pharmacodynamics of flucytosine in a neutropenic murine disseminated candidiasis model. Antimicrobial Agents and Chemotherapy. 2000 Apr 1; 44(4): 938-42.
19. Osumi M, Yamada N, Okada J, Yamaguchi H, Hiratani T, Plempel M. The effect of bifonazole on the structure of Trichophyton. Arzneimittel-Forschung. 1983 Jan 1;33(10):1484-91.
20. Plempel M, Berg D, Abbink J. Antimycotic characteristics of bifonazole. 1987
21. Plempel M, Regel E, Büchel KH. Antimycotic efficacy of bifonazole in vitro and in vivo. Arzneimittel-Forschung. 1983 Jan 1; 33(4): 517-24.
22. Gujjarappa R, Kabi AK, Sravani S, Garg A, Vodnala N, Tyagi U, Kaldhi D, Velayutham R, Singh V, Gupta S, Malakar CC. Overview on biological activities of imidazole derivatives. Nanostructured Biomaterials: Basic Structures and Applications. 2022 Mar 8: 135-227.
23. Lavanya G, Sunil MM, Eswarudu MM, Eswaraiah MC, Harisudha K, Spandana BN. Analytical method validation: an updated review. International Journal of Pharmaceutical Sciences and Research. 2013 Apr 1; 4(4):1280..
24. Pranshu T, Singh RP, Vikash J. Validation: A critical parameter for quality control of pharmaceuticals. Journal of Drug Delivery and Therapeutics. 2012; 2(3): 34-40.
25. Ravisankar, P., S. Gowthami, and G. Devlala Rao. A review on analytical method development. Indian Journal of Research in Pharmacy and Biotechnology. 2014; 2(3): 1183.
26. Vidushi Y, Meenakshi B, Bharkatiya M. A review on HPLC method development and validation. Res J Life Sci, Bioinform, Pharm Chem Sci. 2017; 2(6): 178.
27. Nnachi AB. Advances in UV spectroscopy for monitoring the environment. RIJBAS. 2024; 3(1): 82.
28. Maurya RK, Kumar GP, Singh G, Malik J, Singh SP, Tiwari A. Recent developments in UV-Spectroscopy techniques for quantitative analysis in pharmaceutical dosage forms. International Journal of Pharmaceutical Science and Medicine 2024; 2(1): 21-27
29. Kryczyk-Poprawa A, Żmudzki P, Hubicka U. Determination of bifonazole and identification of its photocatalytic degradation products using UPLC-MS/MS. Biomed Chromatogr. 2017 Sep;31(9). doi: 10.1002/bmc.3955.
30. Prajapati SR, Nagar AR, Hamrapurkar PD. Analytical method development and validation of Bifonazole and It’s stability study by using sophisticated RP-HPLC method. World Journal of Pharmaceutical Research. 2023; 12(6):643-652.
31. Čudina OA, Čomor MI, Janković IA. Simultaneous determination of bifonazole and benzyl alcohol in pharmaceutical formulations by reverse-phase HPLC. Chromatographia. 2005 Apr; 61(7): 415-8.
32. Wahab SI, Zaheer Z. An RP-HPLC method developed for determination of bifonazole in pharmaceutical formulation. Bulletin of Pharmaceutical and Medical Sciences. 2013; 1(1).
33. Chiarentin L, Moura V, Pais AA, Vitorino C. AQbD Approach Applied to NIR in a Complex Topical Formulation: Bifonazole as Case Study. Pharmaceutics. 2025 Jun 26; 17(7): 835.
34. Popović G, Čakar M, Agbaba D. Determination of bifonazole in creams containing methyl-and propyl p-hydroxybenzoate by derivative spectrophotometric method. Journal of pharmaceutical and biomedical analysis. 2003 Sep 15;33(1):131-6.
35. Antypenko LM, Gladysheva SA, Korzhova AS. Development and validation of UV spectrophotometric procedure for estimation of bifonazole in bulk.2016; 4(4): 111-115.
36. Ismail NB, Narayana B, Divya K. Validated spectrophotometric methods for the determination of bifonazole in pharmaceuticals by charge transfer complexation. Journal of the Association of Arab Universities for Basic and Applied Sciences. 2016 Feb 1;19:8-14.
37. Wahab SI, Zaheer Z, Ali SA. Validated UV spectrophotometric method for estimation of bifonazole in their bulk drug and cream pharmaceutical formulation. Inventi Rapid-Pharm Analysis and Quality Assurance. 2013 Apr 19;3:1-3
38. Sonaglioni D, Capaccioli S, Tombari E. Bifonazole: a missing case of polymorphism. Journal of Thermal Analysis and Calorimetry. 2025 May; 150(9):6777-83.